Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: A diagnostic tool in select cases?

University Hospital Munich, Germany.
Cephalalgia (Impact Factor: 4.12). 07/2011; 31(10):1074-81. DOI: 10.1177/0333102410394673
Source: PubMed

ABSTRACT Differential diagnoses of the reversible cerebral vasoconstriction syndrome (RCVS) include all forms of intracranial stenotic disease, such as primary or secondary vasculitis of the central nervous system. Here, we tested the hypothesis that angiographic response to intra-arterial nimodipine application may be helpful in differentiating between RCVS and other entities.
A digital subtraction angiographic (DSA) series of nine consecutive patients with suspected RCVS that were treated by intra-arterial nimodipine due to clinical worsening were retrospectively analyzed. Pre- and post-therapeutic DSA findings of patients with later-confirmed RCVS were compared to those in which another diagnosis was finally made.
Intra-arterial nimodipine resulted in a normalization of both the diameter of the main trunks of the cerebral vessels and the caliber of the peripheral vessels in all RCVS patients. This was not the case in the non-RCVS patients, in whom only a slight general vasodilatation was observed.
Our preliminary results indicate that angiographic response to intra-arterial application might be a helpful differential diagnostic tool in select patients with suspected RCVS.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Reversible cerebral vasoconstriction syndrome (RCVS) is a clinico-radiological syndrome characterized by recurrent thunderclap headache, with or without neurologic symptoms, and reversible vasoconstriction of cerebral arteries. RCVS affects patients in various racial and ethnic groups and in all age groups, although most commonly in the fourth decade of life. Many conditions and exposures have been linked to RCVS, including vasoactive drugs and the peripartum period. Disturbance of the cerebral vascular tone is thought to contribute to the disease's pathophysiology. RCVS generally follows a monophasic course. Associated strokes and cerebral hemorrhages are not uncommon. In this review we will attempt to provide a comprehensive overview of RCVS, with emphasis on the controversies in the field and the newest findings in the reported literature.
    Current Pain and Headache Reports 09/2014; 18(9):443. DOI:10.1007/s11916-014-0443-2 · 2.26 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study summarizes recent advances in neuroimaging of therapy-related brain tissue abnormalities.
    Current Opinion in Neurology 06/2014; DOI:10.1097/WCO.0000000000000108 · 5.73 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cerebral vasculitis is a rare cause of juvenile stroke. It may occur as primary angiitis of the CNS or as CNS manifestation in the setting of systemic vasculitis. Clinical hints for vasculitis are headache, stroke, seizures, encephalopathy and signs of a systemic inflammatory disorder. Diagnostic work up includes anamnesis, whole body examination, laboratory and CSF studies, MRI, angiography and brain biopsy. Due to the rarity of the disease exclusion of more frequent differential diagnoses is a key element of diagnostic work up. This review summarizes the steps that lead to the diagnosis of cerebral vasculitis and describes the red flags and pitfalls. Despite considering the dilemma of angiography-negative vasculitis and false-negative brain biopsy in some cases, it is important to prevent patients from "blind" immunosuppressive therapy in unrecognized non-inflammatory differential diagnosis.
    Clinical & Experimental Immunology 10/2013; 175(3). DOI:10.1111/cei.12221 · 3.28 Impact Factor